Welcome to our dedicated page for Exponent SEC filings (Ticker: EXPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Exponent Inc filings document operating results, Regulation FD disclosures, capital-return actions, and governance matters for a science and engineering consulting company. Recent Form 8-K reports record quarterly financial results, dividend declarations, and share repurchase authorizations tied to the company’s common stock.
Proxy materials cover shareholder voting matters, director elections, executive compensation, pay-versus-performance tables, and board governance. The filing record also includes material-event disclosures related to leadership and corporate governance, along with capital-structure disclosures relevant to Exponent’s public-company reporting.
EXPONENT INC Group Vice President Joseph Sala reported compensation-related equity activity. On March 11, 2026, he exercised 3,180 Restricted Stock Units granted on March 11, 2022, converting them into 3,180 shares of Common Stock on a 1:1 basis.
To cover tax withholding obligations, 1,114 of these shares were withheld by the company at a value of $70.03 per share, leaving Sala with 2,066 shares of Common Stock held directly after the transactions. The filing shows no remaining derivative (RSU) position from this grant.
Exponent Inc. Group Vice President Maureen T. F. Reitman exercised restricted stock units and settled related taxes in shares. On March 11, 2026, 5,510 vested Restricted Stock Units granted on March 11, 2022 were converted into 5,510 shares of Common Stock on a 1:1 basis.
To satisfy tax withholding obligations, 1,756 shares of Common Stock were withheld by the company at $70.03 per share. After these transactions, Reitman directly owned 39,226 shares of Exponent Common Stock, reflecting a routine compensation-related vesting and tax withholding event rather than an open-market sale.
Exponent Inc. Group Vice President Joseph Rakow exercised vested equity awards and received new common shares. He converted 5,298 Restricted Stock Units, granted on March 11, 2022, into 5,298 shares of Common Stock on a 1:1 basis. To cover tax withholding obligations, the company withheld 2,353 shares at a value of $70.03 per share, leaving Rakow with 2,945 shares of Common Stock held directly after the transactions. These movements reflect routine equity compensation vesting and associated tax withholding, rather than open-market buying or selling.
Exponent Inc. executive John Pye reported routine equity compensation activity involving restricted stock units and common shares. On March 11, 2026, 5,934 vested restricted stock units were converted into 5,934 shares of common stock on a 1:1 basis, reflecting the vesting of awards originally granted on March 11, 2022.
To cover tax withholding obligations tied to this vesting, 2,384 common shares were withheld by the company at a price of $70.03 per share, a tax-related disposition rather than an open-market sale. After these transactions, Pye directly holds 29,131 shares of Exponent common stock.
Exponent Inc. Group Vice President James Bradley reported routine equity compensation activity. On March 11, 2026, 4,664 vested Restricted Stock Units granted on March 11, 2022 converted into 4,664 shares of common stock on a 1:1 basis. To satisfy tax withholding obligations, the company withheld 1,559 of these shares at a price of $70.03 per share. Bradley retained 3,105 common shares directly following the transactions. The withholding is a tax payment mechanism, not an open-market sale.
Exponent Inc. President & CEO Catherine Corrigan reported routine equity compensation activity. On March 11, 2026, she exercised vested Restricted Stock Units covering 12,716 shares of common stock on a 1:1 basis, converting them into 12,716 shares of common stock at a stated price of $0.00 per share.
To satisfy tax withholding obligations tied to this vesting, 6,156 common shares were withheld by the company at a reference price of $70.03 per share, according to the filing footnotes. After these transactions, Corrigan directly holds 100,969 shares of Exponent common stock. This filing reflects compensation-related vesting and associated tax withholding, not an open-market purchase or sale.
Exponent Inc. Group Vice President Maureen T. F. Reitman reported a bona fide gift of 140 shares of Exponent common stock. The gift was recorded at a price of $0.00 per share and is classified as a disposition by gift, not an open-market sale. After this transaction, she directly owns 35,472 shares of Exponent common stock.
Exponent, Inc. is a science and engineering consulting firm that helps clients analyze failures, manage risk, and develop products across more than 90 technical disciplines. It operates two segments, Engineering and Other Scientific and Environmental and Health, with 17 specialized practices ranging from biomechanics and data sciences to chemical regulation and health sciences.
Clients span industries such as consumer products, energy, transportation, and chemicals, which represented about 21%, 20%, 16% and 11% of 2025 revenues. Work is typically project-based and billed hourly at professional rates from $225 to $1,375. As of January 2, 2026, the company employed 1,212 people, including 949 technical staff and 731 with doctorates.
The aggregate market value of common stock held by non‑affiliates was approximately $3.0 billion as of July 4, 2025, and 49,254,339 shares were outstanding as of February 20, 2026. Key risks include volatile, event‑driven demand, competition, reliance on highly skilled personnel, regulatory and tort changes, cybersecurity and data privacy threats, rapid developments in artificial intelligence, international and macroeconomic uncertainty, and potential climate‑related and catastrophic disruptions.
Corrigan Catherine reported acquisition or exercise transactions in this Form 4 filing.
Exponent Inc. President and CEO Catherine Corrigan reported awards of stock options, increasing her potential equity exposure to the company. She received 1,425 Incentive Stock Options and 27,075 Non-Qualified Stock Options, both granted at no cost as part of her compensation.
According to the disclosure, each stock option grant becomes exercisable in four equal annual installments, meaning the rights vest gradually over four years rather than all at once. These are options giving her the right to buy shares in the future; they are not immediate stock purchases or sales.
SCHLENKER RICHARD L JR reported acquisition or exercise transactions in this Form 4 filing.
Exponent Inc EVP & CFO Richard L. Schlenker Jr. reported awards of stock options on February 20, 2026. He received 1,425 incentive stock options and 17,575 non-qualified stock options, each representing rights to buy Exponent shares. According to the footnotes, these options become exercisable in four equal annual installments.